» Articles » PMID: 39455985

Women's Perspectives on the Acceptability of Risk-based Cervical Cancer Screening

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2024 Oct 25
PMID 39455985
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increased knowledge of cervical cancer (CC) risk factors and suboptimal performance of present screening programs has generated interest in shifting from a universal screening approach to one based on individual risk assessment. To inform the future development of risk-based CC screening programs, it is crucial to gain insight into the factors influencing the acceptability of such approach among screening target group women. The aim of this study was to prospectively investigate the acceptability of risk-based CC screening and to identify potential barriers.

Methods: In this qualitative study, one-to-one semi-structured interviews were conducted with a purposeful sample including women aged 30-65 years to explore women's perspectives on the acceptability of risk-based CC screening. The study was conducted in Estonia, and interviews were conducted from March to September 2023. Potential participants were approached in person by a member of the study team or by their healthcare providers at primary care or gynaecology clinics. The interview guides were developed based on the concept of acceptability of healthcare interventions.

Results: Twenty participants (mean age 44.5, SD = 8.6) with diverse backgrounds were interviewed. The seven components of acceptability (affective attitude, burden, ethicality, opportunity costs, perceived effectiveness, self-efficacy, and intervention coherence) were explored as key themes. Generally, women supported risk-based screening. However, we identified several factors that may compromise the acceptability of risk-based screening. The participants were reluctant to accept less intense screening for low-risk women and anticipated that if risk-based approach was implemented, more frequent testing would remain an option. Providing in-person clinician support was expected, requiring additional healthcare resources. Knowledge gaps in CC prevention highlighted the need for accessible information and education. Most women were unworried about sensitive data inclusion in risk score calculations. However, some participants were concerned about potential confidentiality breaches by healthcare workers.

Conclusion: This study indicates that risk-based CC screening is acceptable, except for testing low-risk women less frequently. Our findings underscore the necessity for comprehensive understanding of the needs and concerns of the target group women for program development. Healthcare organizations are required to proactively address these needs by implementing comprehensive information dissemination and efficient communication approaches.

References
1.
van der Waal D, Bekkers R, Dick S, Lenselink C, Massuger L, Melchers W . Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status. Prev Med. 2019; 130:105927. DOI: 10.1016/j.ypmed.2019.105927. View

2.
Tammemagi M, Ruparel M, Tremblay A, Myers R, Mayo J, Yee J . USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2021; 23(1):138-148. PMC: 8716337. DOI: 10.1016/S1470-2045(21)00590-8. View

3.
Vaccarella S, Herrero R, Snijders P, Dai M, Thomas J, Hieu N . Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol. 2008; 37(3):536-46. DOI: 10.1093/ije/dyn033. View

4.
Rainey L, Jervaeus A, Donnelly L, Evans D, Hammarstrom M, Hall P . Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study. Psychooncology. 2019; 28(5):1056-1062. PMC: 6593462. DOI: 10.1002/pon.5051. View

5.
Suurna M, Orumaa M, Ringmets I, Parna K . Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020. BMC Womens Health. 2022; 22(1):545. PMC: 9789641. DOI: 10.1186/s12905-022-02123-z. View